Liu, Liang <br/><br/>
A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer.  [electronic resource] 

 -  International journal of cancer  May 2015 
 - 2216-27 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.29242  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--blood<br/>CA-125 Antigen--blood<br/>CA-19-9 Antigen--blood<br/>Carcinoembryonic Antigen--blood<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Pancreatectomy--methods<br/>Pancreatic Neoplasms--blood<br/>Prognosis<br/>Retrospective Studies